Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries (Q63576617)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries |
clinical trial |
Statements
A Multicenter, Open-label, Single-arm, Extension Study to Assess Long-term Safety of Evolocumab Therapy in Subjects With Clinically Evident Cardiovascular Disease in Selected European Countries (English)
0 references
13 March 2017
0 references
4 December 2022
0 references
1,600
0 references
40 year
0 references
85 year
0 references